Published • loading... • Updated
From Biological Detection to Clinical Decision-Making: Incorporating α-Synuclein Seed Amplification Assays in Parkinson’s Diagnosis
Summary by European Medical Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
From Biological Detection to Clinical Decision-Making: Incorporating α-Synuclein Seed Amplification Assays in Parkinson’s Diagnosis – emjreviews.com
From Biological Detection to Clinical Decision-Making: Incorporating α-Synuclein Seed Amplification Assays in Parkinson’s Diagnosis emjreviews.comhttp://dlvr.it/TTmyWp
From Biological Detection to Clinical Decision-Making: Incorporating α-Synuclein Seed Amplification Assays in Parkinson’s Diagnosis
The post From Biological Detection to Clinical Decision-Making: Incorporating α-Synuclein Seed Amplification Assays in Parkinson’s Diagnosis appeared first on European Medical Journal.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
